Free Newsletter

FEATURES >> 10 largest U.S. patent losses | 15 top blockbuster contenders | Emerging pharma jobs

Related Topics >> Generics

SPOTLIGHT: Stada to buy Forum BioScience

August 31, 2007 — 5:59am ET

Related Stories

Tools

German generics maker Stada is plunking down 56 million euro ($76.6 million) for the U.K. pharma group Forum Bioscience. Antitrust regulators will have to bless the deal. Report

SHARE
WITH:

More stories about Generics

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>